Charles River Laboratories vs Wacker Biotech: CDMO Comparison
Side-by-side comparison of Charles River Laboratories and Wacker Biotech on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Key differences
- Charles River Laboratories has more FDA inspections on record (7 vs 0) — a deeper regulatory paper trail.
- Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
- Charles River Laboratories maintains 2 MHRA / UK GMP certificates; Wacker Biotech does not.
- Composite Signal Score: Charles River Laboratories 92/100 vs Wacker Biotech 82/100 — a 10-point gap reflecting the combined quality, capacity and financial signal.
On a 13-modality CDMO landscape, both Charles River Laboratories and Wacker Biotech qualify as Plasmid DNA manufacturers; Charles River Laboratories carries the higher composite Signal Score for Plasmid DNA programs in this comparison.
What to evaluate for Plasmid DNA programs
Both Charles River Laboratories and Wacker Biotech qualify as Plasmid DNA CDMOs. When choosing between them for Plasmid DNA programs, weigh these four dimensions specifically — each carries through to the side-by-side scorecard above.
GMP grade & purity
Confirm GMP (vs research/HQ) grade, supercoiled percentage, and residual host-cell DNA/RNA and endotoxin specs — these gate downstream vector and mRNA quality.
Fermentation scale & yield
Match fermentation scale and yield to your vector or mRNA demand. Ask about high-yield strains and whether scale-up is validated.
Lead time
Plasmid is a common critical-path bottleneck. Evaluate realistic queue and turnaround against your program timeline.
Regulatory track record
Cross-check FDA 483 history and EMA/MHRA GMP coverage — both shown above and on each profile.
Frequently asked: Charles River Laboratories vs Wacker Biotech
Which has the stronger FDA inspection record, Charles River Laboratories or Wacker Biotech?
Both Charles River Laboratories and Wacker Biotech maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. Charles River Laboratories has 7 FDA inspections on record; Wacker Biotech has 0.
How do Charles River Laboratories and Wacker Biotech compare on European GMP coverage?
Charles River Laboratories holds 9 active EMA GMP certificates and 2 MHRA / UK certificates. Wacker Biotech holds 13 active EMA GMP certificates and 0 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.
Which is better for Plasmid DNA manufacturing — Charles River Laboratories or Wacker Biotech?
Both Charles River Laboratories and Wacker Biotech are tagged as Plasmid DNA CDMOs in our directory, so both are credible options for Plasmid DNA programs. The most important differentiator for Plasmid DNA selection is typically gmp grade & purity: Confirm GMP (vs research/HQ) grade, supercoiled percentage, and residual host-cell DNA/RNA and endotoxin specs — these gate downstream vector and mRNA quality. Review each CDMO's profile and inspection record before shortlisting.
What does the Signal Score gap mean in practice?
Charles River Laboratories carries a Signal Score of 92/100 and Wacker Biotech carries 82/100 — a meaningful lead for Charles River Laboratories. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.
Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.
Find & compare CDMOs →